“This continues to grow into something that’s larger than we first anticipated,” said Ashlie Case Sletvold, of Peiffer Wolf Carr Kane Conway & Wise in Cleveland, who has filed two cases against Horizon Therapeutics, which makes Tepezza.
February 23, 2023 at 06:47 PM
4 minute read
staff reporter
An infusion drug that treats a rare disease has caught the eye of lawyers, who have filed over a dozen cases with more expected in the months ahead.
The drug, Tepezza, which the U.S. Food and Drug Administration approved in 2020, treats thyroid eye disease through intravenous infusions.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
